Literature DB >> 20206896

Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading.

Maryse Palardy1, Anju Nohria, Jose Rivero, Neal Lakdawala, Patricia Campbell, Mahoto Kato, Leslie M Griffin, Colleen M Smith, Gregory S Couper, Lynne W Stevenson, Michael M Givertz.   

Abstract

BACKGROUND: Right ventricular (RV) dysfunction is associated with adverse outcomes in heart failure (HF). Mechanical unloading should be more effective than pharmacologic therapy to reduce RV afterload and improve RV function. We compared RV size and function after aggressive medical unloading therapy to that achieved in the same patients after 3 months of left ventricular assist device (LVAD) support. METHODS AND
RESULTS: We studied 20 patients who underwent isolated LVAD placement (9 pulsatile and 11 axial flow). Echocardiograms were performed after inpatient optimization with diuretic and inotropic therapy and compared with studies done after 3 months of LVAD support. After medical optimization right atrial pressure was 11 +/- 5 mm Hg, mean pulmonary artery pressure 36 +/- 11 mm Hg, pulmonary capillary wedge pressure 23 +/- 9 mm Hg, and cardiac index 2.0 +/- 0.6 L.min.m(2). Preoperatively, RV dysfunction was moderate (2.6 +/- 0.9 on a 0 to 4 scale), RV diameter at the base was 3.1 +/- 0.6 cm, and mid-RV was 3.5 +/- 0.6 cm. After median LVAD support of 123 days (92 to 170), RV size and global RV dysfunction (2.6 +/- 0.9) failed to improve, despite reduced RV afterload.
CONCLUSIONS: RV dysfunction seen on intensive medical therapy persisted after 3 months of LVAD unloading therapy. Selection of candidates for isolated LV support should anticipate persistence of RV dysfunction observed on inotropic therapy. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20206896      PMCID: PMC3913073          DOI: 10.1016/j.cardfail.2009.11.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  36 in total

1.  Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation.

Authors:  A J Bank; S H Mir; D Q Nguyen; R M Bolman; S J Shumway; L W Miller; D R Kaiser; S M Ormaza; S J Park
Journal:  Ann Thorac Surg       Date:  2000-05       Impact factor: 4.330

2.  Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.

Authors:  A Barbone; J W Holmes; P M Heerdt; A H The'; Y Naka; N Joshi; M Daines; A R Marks; M C Oz; D Burkhoff
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

3.  Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction.

Authors:  Frank Lloyd Dini; Umberto Conti; Paolo Fontanive; Diana Andreini; Stefano Banti; Lara Braccini; Salvatore Mario De Tommasi
Journal:  Am Heart J       Date:  2007-07       Impact factor: 4.749

4.  Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected].

Authors:  Micha T Maeder; Angeline Leet; Andrew Ross; Donald Esmore; David M Kaye
Journal:  J Heart Lung Transplant       Date:  2009-04       Impact factor: 10.247

5.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure.

Authors:  S Ghio; A Gavazzi; C Campana; C Inserra; C Klersy; R Sebastiani; E Arbustini; F Recusani; L Tavazzi
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

6.  Right ventricular dysfunction and adverse outcome in patients with advanced heart failure.

Authors:  Michael E Field; Scott D Solomon; Eldrin F Lewis; Daniel B Kramer; Kenneth L Baughman; Lynne W Stevenson; Usha B Tedrow
Journal:  J Card Fail       Date:  2006-10       Impact factor: 5.712

7.  Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

Authors:  Daniel Zimpfer; Philipp Zrunek; Wilfried Roethy; Martin Czerny; Heinz Schima; Leopold Huber; Michael Grimm; Angela Rajek; Ernst Wolner; Georg Wieselthaler
Journal:  J Thorac Cardiovasc Surg       Date:  2007-03       Impact factor: 5.209

8.  Effects of off-pump versus on-pump coronary artery bypass grafting on early and late right ventricular function.

Authors:  Tammy J Pegg; Joseph B Selvanayagam; Theodoros D Karamitsos; Ranjit J Arnold; Jane M Francis; Stefan Neubauer; David P Taggart
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

9.  The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.

Authors:  Jennifer Cowger Matthews; Todd M Koelling; Francis D Pagani; Keith D Aaronson
Journal:  J Am Coll Cardiol       Date:  2008-06-03       Impact factor: 24.094

Review 10.  Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.

Authors:  Stefan Klotz; A H Jan Danser; Daniel Burkhoff
Journal:  Prog Biophys Mol Biol       Date:  2008-02-12       Impact factor: 3.667

View more
  7 in total

1.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

Review 2.  Right side of heart failure.

Authors:  Maya Guglin; Sameer Verma
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 3.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 4.  Evaluating heart failure after implantation of mechanical circulatory support devices.

Authors:  Keyur B Shah; Daniel G Tang; Richard H Cooke; Michael C Kontos; Neil P Lewis; Gundars J Katlaps; Michael L Hess; Vigneshwar Kasirajan
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 5.  INTERMACS and MedaMACS: how will they guide future therapy?

Authors:  Garrick C Stewart; Lynne W Stevenson
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 6.  Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings.

Authors:  Stefano Albani; Luca Mesin; Silvestro Roatta; Antonio De Luca; Alberto Giannoni; Davide Stolfo; Lorenza Biava; Caterina Bonino; Laura Contu; Elisa Pelloni; Emilio Attena; Vincenzo Russo; Francesco Antonini-Canterin; Nicola Riccardo Pugliese; Guglielmo Gallone; Gaetano Maria De Ferrari; Gianfranco Sinagra; Paolo Scacciatella
Journal:  Diagnostics (Basel)       Date:  2022-02-07

7.  Relationship between pre-implant interleukin-6 levels, inflammatory response, and early outcome in patients supported by left ventricular assist device: a prospective study.

Authors:  Raffaele Caruso; Luca Botta; Alessandro Verde; Filippo Milazzo; Irene Vecchi; Maria Giovanna Trivella; Luigi Martinelli; Roberto Paino; Maria Frigerio; Oberdan Parodi
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.